| Researchers Debate
Recreational Use Of Erectile Dysfunction Drugs
January 05, 2005
Leaders in the field of sexual
medicine will actively debate the use of
oral pills for erectile dysfunction (ED) at
the 7th Congress of the European Society for
Sexual Medicine inLondon, UK.
Moderated by Irwin Goldstein, MD, editor of
the Journal of Sexual Medicine, the exchange
is scheduled to take place on December 5, 2004
in the Palace Suite of the Hilton London Metropole.
Journalists are invited to join a panel posing
questions to the use of oral pills as lifestyle
drugs versus medications strictly for health
problems.
Viagra, or sildenafil citrate, the first of
the PDE-5 inhibitors to hit the market in treatment
of ED in 1998, first got its start as a potential
angina treatment. Since then, vardenafil (Levitra)
and tadalafil (Cialis) have joined the scene,
targeted at millions of men suffering from erectile
dysfunction. Urologists estimate that as many
as 152 million men fall into this group, over
half of all men over the age of 40, yet the
treatment for this ailment appeals to numbers
beyond. While PDE-5 inhibitors are technically
used to enable men to have an erection when
ED is caused by problems like diabetes, depression,
hypertension or prostate surgery, others see
these drugs as an opportunity to enhance their
lifestyle through sexual
performance.
Dimitrios Hatzichristou, MD will argue that
PDE-5 inhibitors are excellent lifestyle drugs.
With other medications treating hair loss, obesity,
and other conditions not severely life-threatening,
PDE-5 inhibitors have a place in the market
for men with and without erectile dysfunction.
“Erectile dysfunction is an important
indicator of serious underlying medical conditions,”
writes Geoff Hackett, MD in a cover story of
pH7 Magazine. He will discuss the points behind
taking PDE-5 inhibitors solely as a medication
for real health problems.
source:-http://www.sciencedaily.com
|
